CRISPR

Recent articles

Research image of enteric neurons in zebrafish.

Opioid receptors may guide formation of gut nervous system in zebrafish

Fish lacking functional copies of the receptors have fewer enteric neurons than usual, but the findings await further validation.

By Olivia Gieger
26 June 2024 | 4 min read
Research image of two fluorescent-stained organoids.

CRISPR gives autism-linked genes a boost, rescues functioning

A modified form of the gene-editing tool increases the expression of CHD8 and SCN2A, showing potential for autism therapies.

By Giorgia Guglielmi
23 May 2024 | 5 min read
A diagram of green neurnons

Cocaine, morphine commandeer neurons normally activated by food, water in mice

Confirming a long-held hypothesis, repeated exposure to the drugs alters neurons in the nucleus accumbens, the brain’s reward center, and curbs an animal’s urge for sustenance.

By Lauren Schenkman
8 May 2024 | 5 min read
A digital rendering of a strand of RNA

New RNA editor boasts increased versatility, safety

The “PRECISE” technique reprograms cells in a way that, unlike DNA editors, avoids potentially permanent off-target effects.

By Charles Q. Choi
11 April 2024 | 4 min read
A slice of a cerebellum.

Mutation in top autism-linked gene may alter eye reflex

The discovery could help clinicians diagnose children who carry mutations in the gene, called SCN2A, and gauge their responses to potential therapies.

By Charles Q. Choi
26 February 2024 | 5 min read
Illustration of a sheet of red and white pills, with the red pills arranged in the form of a question mark.

New template streamlines sharing clinical trial results

This month’s Going on Trial newsletter explores a new tool for communicating with clinical trial participants and their families, among other drug development news.

By Calli McMurray
31 October 2023 | 7 min read
Research image of cerebral organoids.

Method pinpoints cell-specific effects of autism-linked mutations

The approach, which combines CRISPR with single-cell analyses of organoids, suggests that intermediate progenitor cells are especially vulnerable to mutations associated with autism.

By Celia Ford
3 October 2023 | 3 min read
Research images of a Fanzor protein.

Compact kin of CRISPR discovered across eukaryotes

The newfound DNA-cutting enzyme, called Fanzor, can be programmed to edit the human genome and could prove easier to deliver to cells than current CRISPR tools.

By Charles Q. Choi
31 July 2023 | 5 min read
Research image of gene-edited mouse liver cells compared to controls.

Latest ‘prime-editing’ tools tackle delivery, safety issues

The gene-editing advances make it easier to target specific tissues in mice and detect off-target effects.

By Charles Q. Choi
27 June 2023 | 5 min read
Research image of rodent brain scans.

CRISPR tool rids rodents of oxytocin receptors

The approach provides an “off-the-shelf” way for researchers to compare oxytocin function across species, the team says.

By Angie Voyles Askham
14 June 2023 | 3 min read

Explore more from The Transmitter

Double-duty neurons in primary olfactory cortex pick up on more than just scent

The cells recognize not only odors, such as bananas and black licorice—but also images and words associated with those smells, according to single-neuron recordings from 17 people.

By Angie Voyles Askham
9 October 2024 | 7 min read

How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan

The artistic approach can help explain complex ideas frame by frame without diluting the science, Rajan says.

By Olivia Gieger
9 October 2024 | 7 min read

Former Columbia University psychiatrist committed research misconduct, says federal watchdog

Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.

By Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read